Response to global demand for MSD’s medicine prompts €280m investment in Cork and Carlow.
MSD known as Merck in the US, is to create 330 new jobs in Carlow and Cork as part of a €280m investment in manufacturing.
The new jobs are as a result of increased global demand for MSD’s medicines and vaccines produced in Ireland.
The investment will see both sites expand production facilities and capacity to meet that demand.
MSD in Brinny, Co. Cork is an integrated site for the development, testing and manufacturing of biologics, specialising in the fermentation, purification and sterile filling of biotech products. More than 200 new hires will be needed to meet demand for its work on some of the company’s important treatments – medicines for lung cancer, melanoma, hepatitis C and rheumatoid arthritis.
MSD in Carlow, a state-of-the-art manufacturing facility, and the company’s first stand-alone vaccine and biologics facility outside the US, plans to create 120 new roles. Carlow also is an important link in MSD’s network of sites producing our new immuno-oncology treatment for the global market.
More on these jobs
|No of jobs:||330|
|Jobs take effect:||not stated|